Background

Arthritis has been known to exist since prehistoric times. Over 37,000,000 people are currently suffering from some form of rheumatic disease, resulting in tens of billions of dollars in health care costs and lost productivity. This protocol provides the means of returning these people to an active, productive life through the safe and effective use of low dose antibiotics.

Disease Mechanism

This protocol views inflammatory rheumatism as a persistent, cell-mediated hypersensitivity created by long exposure to antigen (toxins) derived from a hidden or invisible microbial source (i.e., mycoplasma or closely related bacterial L forms). It appears that mycoplasma produce their effect in man by creating a cell-mediated response resulting from long-standing cellular parasitism with gradual sensitization of the host through intermittent antigen release from the cells. The therapeutic focus must be on eliminating mycoplasma.